一种具有抗沙门菌感染治疗潜力的PhoQ组氨酸激酶变构抑制剂
本研究探讨合成腙类化合物A16B1对沙门菌PhoP/PhoQ系统的抑制作用及机制。A16B1特异性靶向PhoQ第二跨膜区,与黏菌素协同、减少沙门菌胞内增殖且无细胞毒性,并提高系统性感染沙门菌的蜡螟幼虫存活率。作者认为A16B1是有潜力的沙门菌致病阻断剂。
要点
- A16B1特异性抑制沙门菌PhoP/PhoQ系统活性,作用靶点为PhoQ第二跨膜区。
- A16B1与黏菌素呈协同作用,减少沙门菌胞内增殖且无细胞毒性。
- A16B1提高系统性感染沙门菌的蜡螟幼虫存活率。
核心结论
- A16B1通过新型抑制机制选择性抑制沙门菌PhoP/PhoQ系统活性,是具作为沙门菌致病阻断剂潜力的合成腙类化合物。
研究设计与样本
- 采用PhoP/PhoQ依赖与非依赖报告基因活性检测评估A16B1对PhoP调节子的特异性。
- 采用天然或截短PhoQ的自磷酸化活性试验解析A16B1作用机制。
- 采用庆大霉素保护试验评估A16B1对沙门菌胞内复制的影响。
- 采用棋盘法分析黏菌素与A16B1的增效作用。
- 选用蜡螟幼虫感染模型评估A16B1的体内治疗作用。
主要发现
- A16B1抑制沙门菌PhoP/PhoQ系统活性,特异性靶向PhoQ第二跨膜区。
- A16B1与抗菌肽黏菌素呈协同作用。
- A16B1减少沙门菌胞内增殖且无细胞毒性。
- A16B1提高系统性感染沙门菌的蜡螟幼虫存活率。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The upsurge of antimicrobial resistance demands innovative strategies to fight bacterial infections. With traditional antibiotics becoming less effective, anti-virulence agents or pathoblockers, arise as an alternative approach that seeks to disarm pathogens without affecting their viability, thereby reducing selective pressure for the emergence of resistance mechanisms. OBJECTIVES: To elucidate the mechanism of action of compound N'-(thiophen-2-ylmethylene)benzohydrazide (A16B1), a potent synthetic hydrazone inhibitor against the Salmonella PhoP/PhoQ system, essential for virulence. MATERIALS AND METHODS: The measurement of the activity of PhoP/PhoQ-dependent and -independent reporter genes was used to evaluate the specificity of A16B1 to the PhoP regulon. Autokinase activity assays with either the native or truncated versions of PhoQ were used to dissect the A16B1 mechanism of action. The effect of A16B1 on Salmonella intramacrophage replication was assessed using the gentamicin protection assay. The checkerboard assay approach was used to analyse potentiation effects of colistin with the hydrazone. The Galleria mellonella infection model was chosen to evaluate A16B1 as an in vivo therapy against Salmonella. RESULTS: A16B1 repressed the Salmonella PhoP/PhoQ system activity, specifically targeting PhoQ within the second transmembrane region. A16B1 demonstrates synergy with the antimicrobial peptide colistin, reduces the intramacrophage proliferation of Salmonella without being cytotoxic and enhances the survival of G. mellonella larvae systemically infected with Salmonella. CONCLUSIONS: A16B1 selectively inhibits the activity of the Salmonella PhoP/PhoQ system through a novel inhibitory mechanism, representing a promising synthetic hydrazone compound with the potential to function as a Salmonella pathoblocker. This offers innovative prospects for combating Salmonella infections while mitigating the risk of antimicrobial resistance emergence.
引用
- Lobertti CA, Cabezudo I, Gizzi FO, et al. An allosteric inhibitor of the PhoQ histidine kinase with therapeutic potential against Salmonella infection. J Antimicrob Chemother. 2024. PMID: 38853496. doi:10.1093/jac/dkae151
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。